Marijuana Study Reveals Teens’ ‘Surprising’ Views Of The Drug

Marijuana use continues to become legal in more places, but that doesn’t mean the drug’s popularity among adolescents is growing, a new study finds.

Although disapproval of marijuana use has decreased dramatically among young adults — suggesting that this age group is viewing the drug less negatively — that’s not the case for younger adolescents, according to the study.

The researchers found that disapproval of marijuana use has actually increased among adolescents ages 12 to 14. In 2013, 79 percent of kids in this age group said they strongly disapproved of people using marijuana, up from 74 percent who said the same in 2002.

The finding “was surprising,” given the growing legalization of the drug, said Christopher Salas-Wright, an assistant professor of social work at the University of Texas at Austin and the lead researcher on the study, published Sept. 16 in the American Journal of Drug and Alcohol Abuse.

Colorado Seeks Permission To Grow & Study Pot At State Universities

COLORADO:  After years of trying to stamp out marijuana use on college campuses, Colorado officials are now asking the federal government to allow its state universities to grow their own pot.

The reason, they say, is that the legalization of the drug here has raised questions about its health effects, questions that can only be answered by studying large amounts and different strains of marijuana.

But researchers face bureaucratic hurdles in scoring pot from the one federally approved marijuana farm, a 12-acre facility at the University of Mississippi’s National Center for Natural Products Research.

Pot Scientists Brace for Marijuana Meltdown as Laws Ease

DISTRICT OF COLUMBIA:  The only marijuana available for research in the U.S. is locked down by federal regulators who are more focused on studies to keep people off the drug than helping researchers learn how it might be beneficial.

Marijuana is a trend that “will peak like tobacco then people will see their error,” said Nora Volkow, director of the National Institute on Drug Abuse, which serves as the gatekeeper for U.S. marijuana research through its oversight of a pot farm that grows the only plants that can be used in clinical trials.

Meanwhile, marijuana advocates say NIDA’s control over research has made almost impossible their ability to test the drug against ailments such as pain, cancer-related nausea and epilepsy.

The federal researchers aren’t “set up to study potential medical benefits, so it’s inappropriate for NIDA to have a monopoly on supply,” said Dan Riffle, director of federal policies at the Marijuana Policy Project, a Washington-based group that lobbies to change marijuana laws.